Upon presentation of their paper describing Remune's ineffectiveness, Kahn says it was clear they "did not present an analysis that the sponsor wanted."
"They wanted the right to review all manuscripts," Kahn said of Immune Response, which the researchers refused because it was "clear it was a way to delay publication."
Dr. Ronald B. Moss, vice president of medical and scientific affairs for Immune Response, refused to comment. Calls to the public relations office were not returned.
Both Kahn and Cheng stressed their duty to the patients who participated in the Remune study in publishing their negative data.
"Patients involved in research treatment should be involved with the outcome," Cheng said.
For the researchers, the Immune Response lawsuit endangers the larger issue of scientific freedom and places a conditional value on scientific research.
"They're sort of like bullies in a sandbox--they take their toys and escape," Kahn said of Immune Response.
Read more in News
Florida Election Enters CourtroomRecommended Articles
-
A Day to RememberWorld AIDS Day serves as a focus for a constant struggle Yesterday was the 11th celebration of World AIDS Day,
-
The Gray Berets and Their Computerized PatrolsNot all of those shabby-looking men you see around Harvard at night are muggers. Forget the baggy pants, forget the
-
Studies Change Common Theories on AIDSInfection by the Human Immunodeficiency Virus (HIV) triggers a nearly constant battle between two giants: the body's immune system and
-
Harvard Study: Genes Affect HIV’s AdvanceA new Harvard study provides the most conclusive evidence yet that an HIV patient’s genetic charactersitics affect the rate at
-
MBTA Renovates Harvard Square Subway Stop -
Modern Middle East Studies Secondary Field AnnouncedLast May, as the Middle East played host to a surge of pro-democracy protests and civil unrest, the Department of Near Eastern Languages and Civilizations announced the creation of a new undergraduate Modern Middle East Studies secondary field, an initiative that had been in the works for many years.
